FOXD2 and head and neck cancer: As shown in Figure 8, FOXD2-AS1 expression was related to poor OS in hepatobiliary and pancreatic cancer (Figure 8C), urinary cancer (Figure 8G), and head and neck cancers (Figure 8K).